By FPJ Web Desk
Brazil’s private clinics have signed a deal for an alternative COVID-19 vaccine made by India’s Bharat Biotech. This comes as it also mad...Read More
An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) is set to recommend granting emergency use authori...Read More
Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on...Read More
London: The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved ...Read More
Oxford University on Thursday said that its COVID-19 vaccine candidate has a better immune response a two full-dose regime is used rather...Read More
Russian Direct Investment Fund (RDIF) on Friday said pharma firm AstraZeneca has accepted its offer to use one of the two components of t...Read More
Researchers from the University of Oxford and pharmaceutical major AstraZeneca on Tuesday presented a pooled analysis of phase 3 trials o...Read More
By Free Press Journal
This column provides latest update from around the world on coronavirus vaccine.
The Russian Gamaleya research institute has suggested UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19 vac...Read More
AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants.
By Associated Press
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
This column provides latest update from around the world on coronavirus vaccine
Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday told NDTV that the Oxford coronavirus vaccine could be ready as early as ...Read More
London: A vaccine against coronavirus, being developed together by scientists at the University of Oxford and pharma giant AstraZeneca, m...Read More
On Saturday, Serum Institute of India (SII) CEO Adar Poonawalla, took to Twitter and asked if the government will have Rs 80,000 crore ov...Read More
Just days after AstraZeneca resumed trials of the COVID-19 vaccine, the University of Oxford has said that the unexplained illness observ...Read More
After clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, the Serum Institute of Ind...Read More
London: Biopharmaceutical giant AstraZeneca and the University of Oxford on Saturday said that clinical trials for their coronavirus vacc...Read More
The trials of the University of Oxford-developed COVID-19 vaccine were put to a halt after one participant developed a serious neurologic...Read More